TearLab Corp (NASDAQ:TEAR)
During the Trading Day
| 11.08 |  -0.11 / -0.98% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 11.32 |  +0.2419 / +2.18% |
Volume: 24.7K |
Latest TEAR News | Press Releases
No recent news for TearLab Corp.
Today’s Trading
| Previous close | 11.19 |
| Today’s open | 11.17 |
| Day’s range | 11.00 - 11.36 |
| Volume | 386,914 |
| Average volume (3 months) | 527,192 |
| Market cap | $324.2M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -52.00% |
| Earnings growth (this year) | +11.93% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +86.44% |
| P/E ratio | NM |
| Price/Sales | 26.39 |
| Price/Book | 21.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IMMUImmunomedics Inc | +0.13 | +3.02% |
| --Biozoom Inc | -0.35 | -8.20% |
| CYNOCynosure Inc | -0.28 | -1.15% |
| ARAYAccuray Inc | -0.09 | -1.53% |
Data as of 4:00pm ET, 06/19/2013
Financials
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $4.0M |
| Annual profit (last year) | -$19.3M |
| Net profit margin | -487.68% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman, Chief Executive Officer & Secretary Elias Vamvakas |
Vice President- Operations Robert Walder, MD |
Corporate headquarters San Diego, California |
Forecasts
